NCT05263219 2023-06-22
DEB-TACE+HAIC vs. HAIC for Large HCC
Second Affiliated Hospital of Guangzhou Medical University
Phase 3 Unknown
Clinical Trials
11 trialsNCT04138381 2023-03-27
SeliGIST
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2 Unknown
NCT05635149 2022-12-02
Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Unknown
NCT02244567 2021-02-02
U-C OC IN PCOS
Beni-Suef University
Phase 1 Unknown
NCT03489616 2018-04-05
CRAGMOLC
Shandong Cancer Hospital and Institute
Phase NA Unknown
NCT03191773 2017-06-20
A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies
Second Affiliated Hospital of Guangzhou Medical University
Phase 1/2 Unknown
NCT01027676 2013-11-14
Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC)
National Cancer Center, Korea
Phase 1/2 Unknown
NCT00319007 2007-08-10
Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis
Radboud University Medical Center
Phase 2 Unknown
NCT00226473 2006-06-21
Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma
Dermatologic Cooperative Oncology Group
Phase 4 Unknown
NCT00285675 2006-05-31
Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004
Novacea
Phase 2 Unknown
NCT00201630 2005-09-20
Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy
New York Prostate Institute
Phase 3 Unknown